The NAFLD Liver Fat Score utilises diagnostic markers such as FSI, AST and AST/ALT ratio, Metabolic Syndrome characteristics, Type 2 diabetes mellitus, and has been validated in MASLD populations with an AUROC ranging from 0.80 to 0.87 [153, 158]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.